Wide spectrum antibiotic from the Aminoglycosides group, derived from Kanamycin

Specification – pharmacopeia: EP

Therapeutic category: antibacterial

Treatment: in some serious infections caused by bacteria such as staphylococci or meningitis; also for treatment of blood infections, abdomen area, lungs, skin, bones, joints and urinary tract.

Pharmacology: Amikacin binds to the 30s subunit of the bacterial ribosome, preventing the read of the RNA, thus prevents the synthesis of necessary proteins for its growth and development.

Aplicación: human

CAS number: 39831-55-5

Chemical formula: C22H45N5O17S